)
John Friend, MD
Chief Executive Officer
Kazia Therapeutics
Dr. John Friend is a highly experienced oncology and hematology drug developer, driven by a passion for improving the lives of cancer patients. In a career spanning more than 25 years, Dr. Friend has worked across a wide range of therapeutic areas in roles from early clinical research through to medical affairs. He was formerly the Senior Vice President of Medical and Scientific Affairs for the U.S. business unit of Helsinn Therapeutics and most recently the Chief Medical Officer at Cellectar Biosciences, a clinical-stage, oncology-focused biotech company in the U.S. Dr. Friend gained his medical degree at Rutgers University (UMDNJ-Robert Wood Johnson) and also holds a BA in chemistry from Southern Methodist University.
Sessions
-
23-Jun-2026Theater 3Kazia Therapeutics
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}